Publication:
Altered blood microbiome in patients with HCV-related Child-Pugh class B cirrhosis

dc.contributor.authorBrochado-Kith, Oscar
dc.contributor.authorRava, Marta
dc.contributor.authorBerenguer, Juan
dc.contributor.authorGonzález-García, Juan
dc.contributor.authorRojo, David
dc.contributor.authorDíez, Cristina
dc.contributor.authorHontañón, Víctor
dc.contributor.authorVirseda-Berdices, Ana
dc.contributor.authorIbañez-Samaniego, Luis
dc.contributor.authorLlop-Herrera, Elba
dc.contributor.authorOlveira, Antonio
dc.contributor.authorPérez-Latorre, Leire
dc.contributor.authorBarbas, Coral
dc.contributor.authorFernandez-Rodriguez, Amanda
dc.contributor.authorResino, Salvador
dc.contributor.authorJimenez-Sousa, Maria Angeles
dc.contributor.authorESCORIAL Study Group
dc.contributor.funderInstituto de Salud Carlos III
dc.contributor.funderMinisterio de Ciencia e Innovación (España)
dc.contributor.funderMinisterio de Ciencia, Innovación y Universidades (España)
dc.contributor.funderUnión Europea. Fondo Europeo de Desarrollo Regional (FEDER/ERDF)
dc.contributor.funderUnión Europea. Comisión Europea. NextGenerationEU
dc.contributor.funderCentro de Investigación Biomédica en Red - CIBERINFEC (Enfermedades Infecciosas)
dc.date.accessioned2024-10-30T08:07:06Z
dc.date.available2024-10-30T08:07:06Z
dc.date.issued2024-10
dc.description.abstractBackground: Altered bacterial translocation is associated with changes in hepatic function and the progression from compensated to decompensated cirrhosis. Child-Turcotte-Pugh (CTP) score is an essential indicator of liver severity. Thus, we aimed to study differences in the blood microbiome together with metabolome profile between HCV-infected patients with CTP class B (CTP-B, significant functional compromise) and patients with CTP class A (CTP-A, well-compensated cirrhosis). Methods: We conducted a cross-sectional study in patients with advanced HCV-related cirrhosis (n = 88) stratified by CTP-B and CTP-A. Bacterial 16S rRNA sequencing was sequenced by MiSeq Illumina technology and non-targeted metabolomics was performed by GC-MS and LC-MS ESI+ and ESI- to complement the analysis. Results: Patients with CTP-B had lower levels of richness (Chao1), and alpha diversity (Shannon and Simpson indexes) at phylum level than patients with CTP-A. Likewise, we observed significant differences in beta diversity between groups at phylum, class, and order levels, showing lower diversity in patients with CTP-B. Higher relative abundance of Proteobacteria (p = 0.012), Alphaproteobacteria (p = 0.005), Sphingomonadales (p = 0.012) and Sphingomonadaceae (p = 0.016) were significantly associated with CTP-B. The phylum Proteobacteria was positively correlated with ethanolamine and oleic acid (p = 0.005 and p = 0.004, respectively) and negatively with p-cresol (p = 0.006). In addition, the order Sphingomonadales and the family Sphingomonadaceae was also negatively correlated with p-cresol (p = 0.001 and p = 0.001). Conclusions: Blood microbial diversity was significantly decreased in patients with CTP-B, who presented an enrichment of Proteobacteria, Alphaproteobacteria, Sphingomonadales and Sphingomonadaceae compared to patients with CTP-A.
dc.description.peerreviewed
dc.description.sponsorshipThis study was supported by grants from Instituto de Salud Carlos III (ISCIII; grant numbers CP17CIII/00007, PI18CIII/00028 and PI21CIII/00033 to MAJS, PI17/00657 and PI20/00474 to JB, PI17/00903 and PI20/00507 to JGG, and PI17CIII/00003 and PI20CIII/00004 to SR) and Ministerio de Ciencia e Innovación (PID2021–126781OB-I00 funded by MCIN/AEI/10.13039/501100011033 and by “ERDF A way of making Europe” to AFR). The study was also funded by CIBER - Consorcio Centro de Investigación Biomédica en Red - (CB 2021; CB21/13/00044), Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación and Unión Europea - NextGenerationEU. CB and DR acknowledge funding from the Ministerio de Ciencia, Innovación y Universidades (RTI2018–095166-B-I00)
dc.format.number10
dc.format.page102524
dc.format.volume17
dc.identifier.citationJ Infect Public Health. 2024 Oct;17(10):102524.
dc.identifier.doi10.1016/j.jiph.2024.102524
dc.identifier.e-issn1876-035X
dc.identifier.issn1876-0341
dc.identifier.journalJournal of infection and public health
dc.identifier.pubmedID39241484
dc.identifier.urihttps://hdl.handle.net/20.500.12105/25374
dc.language.isoeng
dc.publisherElsevier
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/CP17CIII/00007
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/PI18CIII/00028
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/PI21CIII/00033
dc.relation.projectIDinfo:eu-repo/grantAgreement/ISCIII/Plan Estatal de Investigación Científica y Técnica y de Innovación 2013-2016 (ISCIII)/PI17%2F00657/ES/MORBILIDAD Y MORTALIDAD A LARGO PLAZO TRAS LA ERRADICACION DEL VHC EN PACIENTES COINFECTADOS POR VIH%2FVHC CON FIBROSIS HEPATICA AVANZADA%2FCIRROSIS/
dc.relation.projectIDinfo:eu-repo/grantAgreement/ISCIII/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 (ISCIII)/PI20%2F00474/ES/INFECCIONES AGUDAS%2FRECIENTES Y REINFECCIONES POR VHC EN HOMBRES QUE TIENEN SEXO CON HOMBRES CON Y SIN VIH/
dc.relation.projectIDinfo:eu-repo/grantAgreement/ISCIII/Plan Estatal de Investigación Científica y Técnica y de Innovación 2013-2016 (ISCIII)/PI17%2F00903/ES/MORBILIDAD Y MORTALIDAD A LARGO PLAZO TRAS LA ERRADICACION DEL VHC EN PACIENTES COINFECTADOS POR VIH%2FVHC CON FIBROSIS HEPATICA AVANZADA%2FCIRROSIS/
dc.relation.projectIDinfo:eu-repo/grantAgreement/ISCIII/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 (ISCIII)/PI20%2F00507/ES/INFECCIONES AGUDAS%2FRECIENTES Y REINFECCIONES POR VHC EN HOMBRES QUE TIENEN SEXO CON HOMBRES CON Y SIN VIH/
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/PI17CIII/00003
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/PI20CIII/00004
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/PID2021–126781OB-I00
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/CB21/13/00044
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/RTI2018–095166-B-I00
dc.relation.publisherversionhttps://doi.org/10.1016/j.jiph.2024.102524
dc.repisalud.centroISCIII::Centro Nacional de Epidemiología (CNE)
dc.repisalud.centroISCIII::Centro Nacional de Microbiología (CNM)
dc.repisalud.institucionISCIII
dc.repisalud.instituteIIS::IdiPAZ - Instituto de Investigación Sanitaria Hospital La Paz (Madrid)
dc.repisalud.instituteIIS::IiSGM - Instituto de Investigación Sanitaria Gregorio Marañón (Madrid)
dc.rights.accessRightsopen access
dc.rights.licenseAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectChild-Pugh
dc.subjectChronic hepatitis C
dc.subjectCirrhosis
dc.subjectHIV
dc.subjectMetabolome
dc.subjectMicrobiome
dc.subject.meshAdult
dc.subject.meshAged
dc.subject.meshBacteria
dc.subject.meshBlood
dc.subject.meshCross-Sectional Studies
dc.subject.meshFemale
dc.subject.meshHepatitis C, Chronic
dc.subject.meshHumans
dc.subject.meshLiver Cirrhosis
dc.subject.meshMale
dc.subject.meshMetabolome
dc.subject.meshMetabolomics
dc.subject.meshMicrobiota
dc.subject.meshMiddle Aged
dc.subject.meshRNA, Ribosomal, 16S
dc.subject.meshSeverity of Illness Index
dc.titleAltered blood microbiome in patients with HCV-related Child-Pugh class B cirrhosis
dc.typeresearch article
dc.type.hasVersionVoR
dspace.entity.typePublication
relation.isAuthorOfPublication4b55d338-847c-4d74-b564-7015194ee4f4
relation.isAuthorOfPublicationd61ef7a1-b898-4ab4-a595-55eca1e382e7
relation.isAuthorOfPublicationd18c653c-226a-4a2f-9a10-e2b5af9c3b33
relation.isAuthorOfPublication6a32a4a3-2d81-43c5-8295-48346efbf498
relation.isAuthorOfPublication89b17350-14e3-4dfd-b797-6ee6ca5363b8
relation.isAuthorOfPublication2bf7faec-7f00-44ba-9494-efb396305551
relation.isAuthorOfPublication.latestForDiscovery4b55d338-847c-4d74-b564-7015194ee4f4
relation.isFunderOfPublication7d739953-4b68-4675-b5bb-387a9ab74b66
relation.isFunderOfPublication289dce42-6a28-4892-b0a8-c70c46cbb185
relation.isFunderOfPublication1aef4c3b-1ee5-4534-83b4-3f3811c67280
relation.isFunderOfPublicationefa64f05-b985-4984-8f1e-5fc4ef21f502
relation.isFunderOfPublication54f29c6e-1163-4239-8d1d-a0f297ca06e6
relation.isFunderOfPublication0b5a6d3a-4d4d-4346-9bcc-9359bbe13e72
relation.isFunderOfPublication.latestForDiscovery7d739953-4b68-4675-b5bb-387a9ab74b66
relation.isPublisherOfPublication7d471502-7bd5-4f7a-90a4-8274382509ef
relation.isPublisherOfPublication.latestForDiscovery7d471502-7bd5-4f7a-90a4-8274382509ef

Files

Original bundle

Now showing 1 - 2 of 2
Loading...
Thumbnail Image
Name:
AlteredBloodMicrobiomePatients_2024.pdf
Size:
2.29 MB
Format:
Adobe Portable Document Format
Loading...
Thumbnail Image
Name:
Supplementary_AlteredBloodMicrobiomePatients_2024.pdf
Size:
670.85 KB
Format:
Adobe Portable Document Format